Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
GMED
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Is it the Right Time to Add Phibro Stock to Your Portfolio?
Phibro Animal Health's PAHC Animal Health segment is gaining momentum from strong legacy demand, Zoetis medicated feed additives (MFA) acquisition and broad product growth. The vaccine business is expanding on higher demand, capacity inves…
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
Smith+Nephew SNN recently announced the European commercial launch of its CARTIHEAL AGILI-C Cartilage Repair Implant, expanding the availability of its cartilage repair technology across key markets in the region. The launch marks another…
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
Hims & Hers Health HIMS has entered the last quarter of 2026 with strong momentum from weight loss offerings, international expansion and AI-enabled care. However, gross margin pressure from changing business mix, regulatory uncertainty su…
10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research
10x Genomics, Inc. TXG recently announced a multi-project research collaboration with Fred Hutchinson Cancer Center to advance single-cell and spatial technologies across solid tumors and blood cancers. The collaboration will focus on biom…
Here's Why You Should Retain WAT Stock in Your Portfolio for Now
Waters WAT is well-poised for growth in the coming quarters, driven by sustained demand for analytical sciences, an extended instrument replacement cycle, BD integration and synergies, product innovation and growing opportunities in biosep…
Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Split On Outlook
Globus Medical's updated analyst narrative centers on a modest reset in its price target, with the Fair Value estimate moving from US$103.23 to US$100.92. This shift lines up with a split analyst view, where some highlight earnings power a…
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness,…
BDX Expands U.S. Manufacturing With $19B Healthcare Investment
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a landmark partnership with the U.S. Government to expand domestic manufacturing of essential medical consumables and strengthen healthcare supply-chain resilienc…
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2027 performance and strength in Health Savings Accounts (HSAs), is expected to contribute further. However, d…
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
Veeva Systems VEEV continues to strengthen its position in the life sciences software market as its Veeva DQS (Data Quality System) platform expands its reach across clinical trials. The company said that the solution has now supported dat…
Reasons to Add Globus Medical Stock to Your Portfolio Now
Globus Medical, Inc. GMED is gaining market share in the musculoskeletal solutions space, banking on the strong performance of its implantable devices, biologics, accessories and unique surgical instruments. Also, product innovation and so…
Charles River Gains 75.8% in a Year: What's Driving the Rally?
Charles River Laboratories International CRL has witnessed strong momentum over the past year. Shares of the company have risen 75.8%, outperforming the industry's 10.5% growth. The S&P 500 composite has increased 16.1% during the same tim…
Is This the Right Time to Add TMO Stock to Your Portfolio?
Thermo Fisher Scientific Inc. TMO is strengthening growth through innovation, artificial intelligence (AI) investments, customer partnerships and a broad commercial engine. Targeted acquisitions are further broadening its capabilities acro…
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Teleflex's TFX Vascular business is well-positioned for growth in the upcoming quarters, led by sustained demand for central access and hemostatic products, coupled with new product introductions such as EZPLAZ. Further, the company's expa…
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now
Merit Medical Systems, Inc. MMSI is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by solid product performance, global expansion and strategic M&A, is expected to contribute furt…
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
GE HealthCare Technologies Inc. GEHC recently announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based contract manufacturing organization (CMO) specializing in PET radiopharmaceuticals, for $945 million in cash. The acq…
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific
For Immediate Release Chicago, IL – October 6, 2026 – Today, Zacks Equity as Globus Medical GMED, Intuitive Surgical ISRG and Thermo Fisher Scientific TMO. Industry: Medical Instruments Link: https://www.zacks.com/ commentary/2999820/3-med…
Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines
Medical Devices & Supplies - Specialty Stocks Q2 Earnings Review: Inspire Medical Systems (NYSE:INSP) Shines As the Q2 earnings season wraps, let's dig into this quarter's best and worst performers in the medical devices & supplies - speci…
Reasons to Retain Doximity Stock in Your Portfolio for Now
Doximity DOCS is entering a pivotal phase as it accelerates investments in artificial intelligence (AI) to expand beyond its core physician engagement platform. While robust physician adoption, growing enterprise AI deployments and excepti…
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Veeva Systems VEEV recently announced that Servier has selected Veeva OpenData to standardize customer reference data across more than 80 countries. The move strengthens Veeva's position as a key provider of data solutions for global life…
Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
Inspire Medical Systems, Inc. INSP recently announced that the American Medical Association's (AMA) CPT Editorial Panel approved new Category I CPT codes for procedures involving a single lead and implantable pulse generator (IPG), includi…
3 Medical Instruments Stocks Using GenAI to Navigate Industry Woes
Generative AI (GenAI) is gaining traction across the Medical Instruments industry as companies move from experimentation to practical applications. The technology is being used togenerate synthetic medical images, simulate disease progress…
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
Neogen NEOG shares have shown impressive momentum so far this year, surging 83%. The stock has outpaced the industry's 21.6% fall and the S&P 500 composite's 11.7% rise. Carrying a Zacks Rank #2 (Buy) at present, the company's Food Safety…
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
Smith+Nephew SNN recently launched the new EVOS PELVIC Plating System, expanding its EVOS trauma platform into pelvic and acetabular fracture management. The launch strengthens the company's orthopedic trauma portfolio by adding a dedicate…
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises
10x Genomics, Inc. TXG recently began commercial shipments of Atera, its next-generation spatial biology platform designed to combine whole-transcriptome analysis, sub-cellular resolution and single-cell sensitivity at scale. The launch ma…
GMED vs. ITGR: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Globus Medical (GMED) and Integer (ITGR). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a close…
Should You Continue to Hold IART Stock in Your Portfolio?
Integra LifeSciences Holdings Corporation IART sees steady demand across Specialty Surgery, supported by neurosurgery strength, better supply reliability and emerging ear, nose and throat (ENT) opportunities. The company is improving opera…
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now
McKesson's MCK prospects are being driven by robust growth in specialty distribution, oncology services and biopharma solutions. Earnings are also improving on the back of ongoing operational efficiency and capital discipline despite persi…
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore
1 Mid-Cap Stock for Long-Term Investors and 2 We Ignore Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense com…
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics' continuous glucose monitoring technology. The collaboration is expe…
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio
Integer Holdings Corporation ITGR has been gaining from its research and product development activities. The optimism, led by a mixed second-quarter 2026 performance and its strength in core product franchises, is expected to contribute fu…
Here's Why You Should Retain Revvity Stock in Your Portfolio for Now
Revvity, Inc. RVTY is well-positioned for growth, thanks to its strong product portfolio. The company is positioned for growth across diagnostics, life sciences and scientific informatics. Diagnostics remains a key growth engine, while new…
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth
Fresenius Medical Care AG & Co. FMS recently refined its China commercial strategy to focus on areas offering stronger long-term growth potential and strengthen its position in the country's dialysis market. The company plans to prioritize…
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Labcorp Holdings Inc. LH, or Labcorp, is expanding in high-growth specialty testing markets while broadening its consumer testing business. Acquisitions, health-system relationships and new contracts are boosting the company's reach and su…
Globus Medical (GMED) Pulls Back Following Recent Weakness, Is The Stock Trading At A Discount?
Globus Medical (GMED) has drawn investor attention after recent price moves left the stock down about 10% over the past month and roughly 5% lower over the past 3 months. Set against that short term pullback, Globus Medical's 1 year total…